Literature DB >> 18281251

GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes.

Graham W Neill1, Wesley J Harrison, Mohammed S Ikram, Tomos D L Williams, Lucia S Bianchi, Sandeep K Nadendla, Judith L Green, Lucy Ghali, Anna-Maria Frischauf, Edel A O'Toole, Fritz Aberger, Michael P Philpott.   

Abstract

Basal cell carcinoma (BCC) of the skin is a highly compact, non-metastatic epithelial tumour type that may arise from the aberrant propagation of epidermal or progenitor stem cell (SC) populations. Increased expression of GLI1 is a common feature of BCC and is linked to the induction of epidermal SC markers in immortalized N/Tert-1 keratinocytes. Here, we demonstrate that GLI1 over-expression is linked to additional SC characteristics in N/Tert-1 cells including reduced epidermal growth factor receptor (EGFR) expression and compact colony formation that is associated with repressed extracellular signal-regulated kinase (ERK) activity. Colony formation and repressed ERK activity remain evident when EGFR is increased exogenously to the basal levels in GLI1 cells revealing that ERK is additionally inhibited downstream of the receptor. Exposure to epidermal growth factor (EGF) to increase ERK activity and promote migration negates GLI1 colony formation with cells displaying an elongated, fibroblast-like morphology. However, as determined by Snail messenger RNA and E-cadherin protein expression this is not associated with epithelial-mesenchymal transition (EMT), and GLI1 actually represses induction of the EMT marker vimentin in EGF-stimulated cells. Instead, live cell imaging revealed that the elongated morphology of EGF/GLI1 keratinocytes stems from their being 'stretched' due to migrating cells displaying inefficient cell-cell detachment and impaired tail retraction. Taken together, these data suggest that GLI1 opposes EGFR signalling to maintain the epithelial phenotype. Finally, ERK activity was predominantly negative in 13/14 BCCs (superficial/nodular), indicating that GLI1 does not routinely co-operate with ERK to induce the formation of this common skin tumour.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281251     DOI: 10.1093/carcin/bgn037

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Hedgehog pathway and GLI1 isoforms in human cancer.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Discov Med       Date:  2012-02       Impact factor: 2.970

2.  Identification, functional characterization, and pathobiological significance of GLI1 isoforms in human cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

3.  GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells.

Authors:  Simon Joost; Luciana L Almada; Verena Rohnalter; Philipp S Holz; Anne M Vrabel; Maite G Fernandez-Barrena; Robert R McWilliams; Michael Krause; Martin E Fernandez-Zapico; Matthias Lauth
Journal:  Cancer Res       Date:  2011-11-15       Impact factor: 12.701

Review 4.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

5.  MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling.

Authors:  Ranadheer Dontula; Ashok Dinasarapu; Chandramu Chetty; Padmavathi Pannuru; Engelhard Herbert; Howard Ozer; Sajani S Lakka
Journal:  Genes Cancer       Date:  2013-07

6.  Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.

Authors:  Harald Schnidar; Markus Eberl; Stefan Klingler; Doris Mangelberger; Maria Kasper; Cornelia Hauser-Kronberger; Gerhard Regl; Renate Kroismayr; Richard Moriggl; Maria Sibilia; Fritz Aberger
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

7.  GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state.

Authors:  Sandeep K Nadendla; Allon Hazan; Matt Ward; Lisa J Harper; Karwan Moutasim; Lucia S Bianchi; Mahmoud Naase; Lucy Ghali; Gareth J Thomas; David M Prowse; Michael P Philpott; Graham W Neill
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

8.  Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.

Authors:  Gabriel T M Lok; David W Chan; Vincent W S Liu; Winnie W Y Hui; Thomas H Y Leung; K M Yao; Hextan Y S Ngan
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene.

Authors:  A M Snijders; B Huey; S T Connelly; R Roy; R C K Jordan; B L Schmidt; D G Albertson
Journal:  Oncogene       Date:  2008-11-17       Impact factor: 9.867

Review 10.  Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.

Authors:  Komaraiah Palle; Chinnadurai Mani; Kaushlendra Tripathi; Mohammad Athar
Journal:  Cancers (Basel)       Date:  2015-11-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.